Anticancer drug screening and discovery in the 1990s: a European perspective.
作者： G. Schwartsmann , P. Workman
DOI: 10.1016/0959-8049(93)90567-Y
关键词: Political science 、 Medical physics 、 General assembly 、 Dose assessment 、 Pharmacology 、 Anticancer drug 、 Perspective (graphical) 、 World health
摘要: 2. World Health Organization. Summary Report ofMeasurement Results Relevant for Dose Assessment. Updated Background Infmtion on the Nuclear Reactor Accident in Chernobyl, USSR. Revision, No. 7. Copenhagen, WHO, 1986. United Nations Scientific Committee Effects of Atomic Radiation. Sources, and Risks Ionizing Radiation, 1988 to General Assembly. New York, Nations, 1988.
sci-hub.se 参考文章(106)
Michael I. Walton, Paul J. Smith, Paul Workman, The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9. Cancer communications. ,vol. 3, pp. 199- 206 ,(1991) , 10.3727/095535491820873164
Peter J. Hylands, Louis J. Nisbet, Chapter 27. The Search for Molecular Diversity (I): Natural Products Annual Reports in Medicinal Chemistry. ,vol. 26, pp. 259- 269 ,(1991) , 10.1016/S0065-7743(08)61214-2
P.L. Crowell, R.R. Chang, Z.B. Ren, C.E. Elson, M.N. Gould, Selective inhibition of isoprenylation of 21-26-kDa proteins by the anticarcinogen d-limonene and its metabolites. Journal of Biological Chemistry. ,vol. 266, pp. 17679- 17685 ,(1991) , 10.1016/S0021-9258(19)47425-5
D Bissett, MA Graham, A Setanoians, GA Chadwick, P Wilson, Koier I, R Henrar, G Schwartsmann, J Cassidy, SB Kaye, DJ Kerr, Phase I and pharmacokinetic study of rhizoxin Cancer Research. ,vol. 52, pp. 2894- 2898 ,(1992)
Christian C. Fizames, Robert R.M. Tilson, François Lavelle, John J.A. Hickman, Simon S.P. Langdon, Ghanem Atassi, Neil N.W. Gibson, Edward E. Lunt, Malcolm F G M.F.G. Stevens, Experimental Antitumor Activity against Murine Tumor Model Systems of 8-Carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (Mitozolomide), a Novel Broad-Spectrum Agent Cancer Research. ,vol. 45, pp. 3008- 3013 ,(1985)
Massimo Broggini, Eugenio Erba, Mauro Ponti, Dario Ballinari, Cristina Geroni, Federico Spreafico, Maurizio D'Incalci, Selective DNA interaction of the novel distamycin derivative FCE 24517. Cancer Research. ,vol. 51, pp. 199- 204 ,(1991)
Christian Fizames, François Lavelle, John A. Slack, David Chubb, John A. Hickman, Robert Stone, Simon P. Langdon, Colin Goddard, Ghousia Baig, Neil W. Gibson, Edward Lunt, Christopher Newton, Malcolm F. G. Stevens, Lisa Vickers, Antitumor Activity and Pharmacokinetics in Mice of 8-Carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a Novel Drug with Potential as an Alternative to Dacarbazine Cancer Research. ,vol. 47, pp. 5846- 5852 ,(1987)
Garth L. Nicolson, Andreas Gescher, Wolfgang E. Berdel, Harold L. Moses, Paul Workman, Thomas R. Tritton, Jean-Pierre Abita, Garth Powis, John Hickman, The Cell Membrane and Cell Signals as Targets in Cancer Chemotherapy AACR, EORTC, and BACR Special Conference in Cancer Research Cancer Research. ,vol. 50, pp. 2203- 2211 ,(1990)
Anthony E. Pegg, Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Research. ,vol. 50, pp. 6119- 6129 ,(1990)
A. M. H. Brodie, G. Hutchison, J.-C. Gazet, T. J. Powles, P. A. Goss, M. Dowsett, R. C. Coombes, Treatment of Advanced Postmenopausal Breast Cancer with an Aromatase Inhibitor, 4-Hydroxyandrostenedione: Phase II Report Cancer Research. ,vol. 46, pp. 4823- 4826 ,(1986)